Critically, timed low-dose STZ after HFD yields a reproducible window for IR onset, allowing side-by-side interrogation of obesity (HFD-only) versus insulin-resistant (HFD + STZ) states in the same genetic background. The gene discussed is INS; the disease is Obesity.